SCHEMBL6743776

SCHEMBL6743776

CCOC(=O)C(C)Oc1c[c]ncn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 3/20 0.42
KMT2A Q03164 3/20 0.36
KDM4E B2RXH2 5/20 0.36
ALDH1A1 P00352 6/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 2/20 0.34
MAPT P10636 2/20 0.33
MAPK1 P28482 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
GAA P10253 1/20 0.33
HTT P42858 1/20 0.33
TP53 P04637 1/20 0.33
EPHX2 P34913 2/20 0.32
CYP1A2 P05177 1/20 0.32
ALOX15 P16050 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6746855 0.85 MEN1 (0.35) L3MBTL1KMT2AKDM4ESMN1; SMN2MEN1
SCHEMBL28034661 0.73 CYP1A2 (0.47) TSHRKMT2AKDM4EALDH1A1MEN1
SCHEMBL6773879 0.71
SCHEMBL15999994 0.69 TSHR (0.46) L3MBTL1LMNATSHRKMT2AKDM4E
SCHEMBL4868427 0.67 L3MBTL1 (0.43) L3MBTL1LMNATSHRKMT2AKDM4E
SCHEMBL11310453 0.67 TSHR (0.56) L3MBTL1LMNATSHRKMT2AKDM4E
SCHEMBL3528428 0.65 TSHR (0.45) L3MBTL1LMNATSHRKMT2AKDM4E
SCHEMBL11012644 0.65 LMNA (0.70) L3MBTL1LMNAKMT2AALDH1A1MEN1
SCHEMBL24701201 0.65 L3MBTL1 (0.50) L3MBTL1LMNATSHRKMT2AKDM4E
SCHEMBL6279361 0.64 L3MBTL1 (0.56) L3MBTL1LMNATSHRKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040023805-A1 Substituted phenyluracils ANDREE ROLAND (DE) 2004-02-05 US disclosed
US-6649760-B2 Herbicides BAYER AKTIENGESELLSCHAFT (DE) 2003-11-18 US disclosed
CN-1420873-A Substituted phenyluracils BAYER AG (DE) 2003-05-28 CN disclosed
EP-1272478-A1 SUBSTITUTED PHENYLURACILS Bayer Aktiengesellschaft (DE) 2003-01-08 EP disclosed
US-20020173425-A1 Substituted phenyluracils BAYER AKTIENGESELLSCHAFT (DE) 2002-11-21 US disclosed
WO-2001077084-A1 SUBSTITUTED PHENYLURACILS BAYER CROPSCIENCE AG (DE) 2001-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173425-A1 Substituted phenyluracils DPYD, POP1, G6PD L3MBTL1 963/4885LMNA 4406/4885TSHR 920/4885
US-20040023805-A1 Substituted phenyluracils DPYD, POP1, G6PD L3MBTL1 963/4885LMNA 4406/4885TSHR 920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.